NexgenRx Inc. announced that a dividend in the amount of one-half of one cent per share ($0.005) has been declared in respect of all of its outstanding series 1 preferred shares. This dividend will be payable on or before October 10, 2022 to all shareholders of record as at the close of business on October 3, 2022. As of the date of this press release, there are a total of 6,600,000 series 1 preferred shares issued and outstanding.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 CAD | 0.00% | +4.55% | +4.55% |
04-05 | NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
+4.55% | 11.94M | |
-1.86% | 118B | |
+3.26% | 95.3B | |
+13.75% | 69.05B | |
+20.25% | 63.76B | |
+12.28% | 43.7B | |
+14.14% | 43.06B | |
+17.76% | 34.41B | |
+3.63% | 24.92B | |
-1.14% | 23.07B |
- Stock Market
- Equities
- NXG Stock
- News NexgenRx Inc.
- NexgenRx Inc. Announces Dividend on its outstanding common shares, payable on or Before October 10, 2022